Competing interests Nik Krajnc: has participated in meetings sponsored by, received speaker honoraria or travel funding from BMS/Celgene, Janssen-Cilag, Merck, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
The therapeutic potential of GLP-1 receptor biased agonism
The patients taking GLP-1 RA medications report that the food noise the constant thinking about food is quieter, Ali said
MOTS-C Insulin Sensitivity & Energy Utilisation MOTS-C is a mitochondrial-derived peptide studied for its effects on: Insulin sensitivity Glucose utilisation Skeletal muscle metabolic efficiency By improving muscle cells ability to utilise glucose, MoTS-C may indirectly influence body fat levels through improved metabolic flexibility
They can also cause rare and occasionally severe side effects including acute pancreatitis and acute gallbladder diseases as well as intestinal obstruction and gastroparesis